Comparative analysis of the incidence of surgical site infections in patients with liver resection for colorectal hepatic metastases after neoadjuvant chemotherapy

J Surg Res. 2014 May 1;188(1):183-9. doi: 10.1016/j.jss.2013.11.1092. Epub 2013 Nov 22.

Abstract

Background: The aim of this study was to identify the incidence of surgical site infections (SSIs) and postoperative complications, as defined by the Clavien-Dindo classification, after hepatic resection for metastatic colorectal cancer in patients with and without associated neoadjuvant chemotherapy.

Methods: A total of 181 patients were studied retrospectively. Patients were divided into two groups: the first group comprised patients with associated neoadjuvant chemotherapeutic treatment for liver metastases with a latency time <8 wk and the second group comprised patients without associated neoadjuvant chemotherapy.

Results: Variables of duration of liver surgery, length of total hospital stay, and length of postoperative hospital stay seem to be correlated with SSIs and postoperative complications, P < 0.005 and P < 0.0001, respectively. Duration of surgery is a risk factor for SSIs, with an odds ratio of 1.15, and for complications according to the Clavien-Dindo classification, with an odds ratio of 1.35.

Conclusions: Neoadjuvant chemotherapy was not a significant risk factor for SSIs, whereas the total length of hospital stay, length of postoperative hospital stay, and duration of surgery were independent predictors of SSIs and complications according to the Clavien-Dindo classification.

Keywords: Clavien–Dindo classification; Colorectal liver metastases; Liver surgery; Neoadjuvant chemotherapy; Risk factors; Surgical site infection.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use
  • Colorectal Neoplasms / pathology
  • Female
  • Humans
  • Incidence
  • Italy / epidemiology
  • Liver / pathology
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Liver Neoplasms / surgery*
  • Male
  • Middle Aged
  • Neoadjuvant Therapy*
  • Retrospective Studies
  • Surgical Wound Infection / epidemiology*

Substances

  • Antineoplastic Agents